Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Alzheimer's Disease

  Free Subscription


29.06.2026

1 Acta Neuropathol
10 Alzheimers Dement
1 Am J Geriatr Psychiatry
1 BMC Geriatr
1 Drugs
7 J Alzheimers Dis
1 J Neurol
1 JAMA
1 Neurobiol Aging
1 Neurology
1 Neuropsychology
1 Neuroreport
4 Neuroscience
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. KAC PR, Cousins KAQ, Szadziewska A, Shaw LM, et al
    Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP.
    Acta Neuropathol. 2026;151:71.
    PubMed         Abstract available


    Alzheimers Dement

  2. CHEN Y, Duggan MR, Timsina J, Xu Y, et al
    Blood-based proteomic signature of amyloidosis: identification of novel regulators of amyloid load.
    Alzheimers Dement. 2026;22:e71611.
    PubMed         Abstract available

  3. YIN H, Deng Y, Lu Z, Jiang Y, et al
    Choroid plexus remodeling linked to impaired CSF-mediated clearance and Alzheimer's disease progression.
    Alzheimers Dement. 2026;22:e71606.
    PubMed         Abstract available

  4. PEROVIC M, Phillips NA, Einstein G
    Sex differences in the association of adverse childhood experiences with brain and cognition along a continuum of risk for Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71612.
    PubMed         Abstract available

  5. ZENG Y, Cook N, Yang C, Sivasankaran SK, et al
    APOE*4 risk-modifying genes and drug targets in Alzheimer's disease through cell-type-specific genomic analyses.
    Alzheimers Dement. 2026;22:e71552.
    PubMed         Abstract available

  6. CORRIVEAU-LECAVALIER N, Falgas N, Putcha D, Graff-Radford J, et al
    Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action.
    Alzheimers Dement. 2026;22:e71521.
    PubMed         Abstract available

  7. WONG J, Wang T, Datta R, Abdollahi RO, et al
    Tau positron emission tomography analysis methods for the quantification of tau spread in preclinical and early Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71573.
    PubMed         Abstract available

  8. DUBOIS KN, Pal S, Maher AC, Heidebrink J, et al
    Dementia etiology classification using NULISA plasma biomarkers and machine learning.
    Alzheimers Dement. 2026;22:e71603.
    PubMed         Abstract available

  9. CHANG A, Kim M, Glittenberg M, Qu W, et al
    HDL-mimetic peptide treatment reverses APOE4-induced transcriptomic and lipidomic alterations in the brain of humanized APOE mice.
    Alzheimers Dement. 2026;22:e71568.
    PubMed         Abstract available

  10. MARTINEZ-OROZCO H, Andrade-Guerrero J, Pasten-Castrejon NJ, Rodriguez-Tanty C, et al
    Redirecting Alzheimer's disease therapeutics: Multitarget drugs and complementary non-pharmacological strategies.
    Alzheimers Dement. 2026;22:e71589.
    PubMed         Abstract available

  11. RUDOLF MA, Ng YT, Lieberman AP
    Sleep fragmentation correlates with amyloid beta deposition at brain autopsy.
    Alzheimers Dement. 2026;22:e71616.
    PubMed         Abstract available


    Am J Geriatr Psychiatry

  12. ROSENBERG PB, Forester BP
    Cannabinoid Treatments for Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2026 Jun 5:S1064-7481(26)00414.
    PubMed        


    BMC Geriatr

  13. YANG X, Wang Y, Qian F, Lu L, et al
    Risk of dementia in older patients with different anesthesia: a systematic review and meta-analysis of cohort studies.
    BMC Geriatr. 2025;25:493.
    PubMed         Abstract available


    Drugs

  14. DA SILVA AMP, Tudella GCN, Goncalves OR, Ribeiro FV, et al
    Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.
    Drugs. 2026;86:1103-1119.
    PubMed         Abstract available


    J Alzheimers Dis

  15. ZHENG X, Tang C, Li H, Wang B, et al
    Postoperative changes in cervical hemodynamics and cognitive function following cervical lymphatic-venous surgery in Alzheimer's disease.
    J Alzheimers Dis. 2026 Jun 26:13872877261459037. doi: 10.1177/13872877261459037.
    PubMed         Abstract available


  16. Corrigendum to "Aluminum involvement in the progression of Alzheimer's Disease".
    J Alzheimers Dis. 2026 Jun 23:13872877261458196. doi: 10.1177/13872877261458196.
    PubMed        

  17. CHOI BK, Park JA, Kim TH, Kim HC, et al
    Monitoring Alzheimer's disease-related fluid microenvironment changes using magnetic resonance-based electrical conductivity imaging.
    J Alzheimers Dis. 2026 Jun 23:13872877261461256. doi: 10.1177/13872877261461256.
    PubMed         Abstract available

  18. KASHIF M, Ho MH, Pandurangan AK, Waseem M, et al
    Vitamin D in Alzheimer's disease: Neuroinflammatory, metabolic, and clinical implications.
    J Alzheimers Dis. 2026 Jun 23:13872877261460850. doi: 10.1177/13872877261460850.
    PubMed         Abstract available

  19. MONTEIRO AMF, Lima Nogueira MM, Barbeito Lacerda I, Belfort T, et al
    When caring becomes a challenge: A path analysis of coping in Alzheimer's disease caregiving.
    J Alzheimers Dis. 2026 Jun 23:13872877261458984. doi: 10.1177/13872877261458984.
    PubMed         Abstract available

  20. DHARMAPURI A, Chaudhuri S, Contreras JA, Hayes CA, et al
    Interleukin-6 is associated with white matter hyperintensities and cognition independent of Alzheimer's disease plasma biomarkers-HABS-HD.
    J Alzheimers Dis. 2026 Jun 24:13872877261458367. doi: 10.1177/13872877261458367.
    PubMed         Abstract available

  21. IVANOVA O
    Language as a central axis for studying Alzheimer's disease: From pathogenesis and clinical practice to scientific theory.
    J Alzheimers Dis. 2026 Jun 26:13872877261461253. doi: 10.1177/13872877261461253.
    PubMed         Abstract available


    J Neurol

  22. CHEN Y, Wang Z, Chen H, Li H, et al
    Plasma p-Tau217 and Abeta42/Abeta40 mediate the association between minimal depressive symptoms and cognitive impairment.
    J Neurol. 2026;273:409.
    PubMed         Abstract available


    JAMA

  23. HSIAO JK
    Stopping Alzheimer Disease: 50 Years of Progress.
    JAMA. 2026 Jun 22. doi: 10.1001/jama.2026.10969.
    PubMed        


    Neurobiol Aging

  24. LOPEZ-MARTOS D, Suarez-Calvet M, Salvado G, Cacciaglia R, et al
    Decreased awareness of cognitive decline is associated with multimodal Alzheimer's disease biomarkers in cognitively unimpaired individuals.
    Neurobiol Aging. 2026;167:76-94.
    PubMed         Abstract available


    Neurology

  25. GALLAY C, Soldevila-Domenech N, Lopez-Martos D, Sanchez-Benavides G, et al
    Effect of Parity and beta-Amyloid on Cognition and Hippocampal Volume in Postmenopausal Women.
    Neurology. 2026;107:e218153.
    PubMed         Abstract available


    Neuropsychology

  26. ROBINSON TL, Montenegro GDC, Fu JF, Pintucci EN, et al
    Digital maze test reveals cognitive performance patterns associated with amyloid-beta and tau.
    Neuropsychology. 2026;40:465-475.
    PubMed         Abstract available


    Neuroreport

  27. ZHENG M, Hou B, Ma R, Tan Z, et al
    Methyltransferase-like 14 alleviates neuronal ferroptosis in Alzheimer's disease by regulating the peroxiredoxin 6/apoptosis signal-regulating kinase 1 signaling pathway.
    Neuroreport. 2026;37:430-441.
    PubMed         Abstract available


    Neuroscience

  28. TOMYSHEV A, Cherkasov N, Panikratova Y, Bozhko O, et al
    Structural MRI and mild behavioral impairment as complementary predictors of conversion from amnestic MCI to Alzheimer's disease.
    Neuroscience. 2026;610:337-351.
    PubMed         Abstract available

  29. AL-KURAISHY HM, Fahad EH, Jabir MS, Rafeeq MF, et al
    Targeting of RhoA-ROCK pathway activators and linked molecular signaling in Alzheimer's disease: The paving dawn for future therapy.
    Neuroscience. 2026 Jun 24:S0306-4522(26)00422.
    PubMed         Abstract available

  30. XU W, Cao J, Liu Y, Wei Z, et al
    LPI alleviates Alzheimer's disease pathology via the GPR55 receptor.
    Neuroscience. 2026 Jun 26:S0306-4522(26)00424.
    PubMed         Abstract available

  31. OHNO M
    Accelerated long-term forgetting and relevant biomarkers for early detection in preclinical Alzheimer's disease.
    Neuroscience. 2026 Jun 26:S0306-4522(26)00407.
    PubMed         Abstract available


    PLoS One

  32. AKHTER F, Samanta S, Sosunov AA, Wu H, et al
    Mitochondrial oxidative stress promotes the accumulation of advanced glycation end products.
    PLoS One. 2026;21:e0352355.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum